Posts tagged “Biotech & Life Science”
The company will build a new bioagriculture research and development facility in Cary. The company said it will invest $36 million over the next three years and create 100 new jobs at the facility. Salaries will start at $70,000.
Plans for pharmaceutical giants Novartis, GlaxoSmithKline and Eli Lilly to swap business lines may have shaken up the stock market Tuesday, but work at a Novartis flu vaccine plant in Holly Springs hummed along, and local officials said they expect it to remain that way.
GSK's top executive Andrew Witty says the multiple deals announced early Tuesday with Novartis promise to deliver "broadly sustainable sourced sales growth and improve long-term earnings."
Two drug giants with major operations in the Triangle, Novartis and GlaxoSmithKline, are swapping businesses in two major deals. Meanwhile, Novartis plans to sell its huge Holly Springs plant in a separate deal and also strikes an agreement to sell its animal health business to Eli Lilly. No layoffs are planned, Novartis says.
Drug giants Novartis and GlaxoSmithKline each offered investors online presentations that spell out graphically how the deals announced Tuesday will affect each company. Here's a look at three key slides from the Novartis presentation.
Drug giants GlaxoSmithKline and Novartis each offered investors online presentations that spell out graphically how the deals announced Tuesday will affect each company. Here's a look at three key slides from the GSK presentation.
TransEnterix, which is developing an innovative robotic surgery platform, completed its move to the NYSE MKT, launched its first "advanced energy flexible instrument," and is ready to take on industry leaders. But CEO Todd Pope says one of his biggest challenges early-on was convincing investors he could build the firm in the Research Triangle.
The Startup Blog: The Research Triangle will be well represented at the upcoming Southeast Venture Conference in Atlanta with numerous firms already selected to be among the "pitchers" at the two-day event.
The Durham drug-development company was expected to go public earlier this month, but a flagging market apparently set the Scynexis plans back. Now, The Wall Street Journal reports that today is the IPO day.
WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.
Neither organization disclosed terms of the arrangement. But they said in a joint news release that the deal makes the combined organization "the largest provider of corneal tissue for transplant in the world."
Opinion: Health care is a misnomer for our medical system. It should be called sick care. Doctors, hospitals and pharmaceutical companies only make money when we are in bad health. If we could instead prevent illness and disease, it would turn the entire medical system on its head and increase the quality of our lives. The good news is that technology is on its way to letting us do this.
The drug giant issues a statement reiterating it has "zero tolerance for unethical or illegal behavior" and says 48 employees were fired in 2013. The statement comes after reports that bribery probes are underway in two more countries.
RTP-based medical device firm TransEnterix pulled off its $50 million stock offering and moved its shares to a different exchange on Tuesday. The company expects to net $46 million from the transaction.
TechLaw: On March 4, 2014, the U.S. Patent and Trademark Office issued new guidelines to its Patent Examiners to assist them in determining which patent claims are not eligible for patenting. The guidelines create hurdles that patent applicants must overcome in their quest for patentable claims.
Bayer CropScience on Tuesday unveiled the 6,000-square-foot building to promote honey bee health and well-being through public education exhibits for visitors, a conference room and a research lab. The vision is to have students mingle with company scientists and other bee experts to study ways to reverse the decline in the important pollinators' populations.
The Obama administration's timeline for having ready the new health care law's online sign-up system "was just flat out wrong," outgoing Health and Human Services Secretary Kathleen Sebelius said in an interview that aired Sunday.